Lewis William's Form 4 filing
INSMED Inc (INSM) · filed Jan 5, 2024
- Accession no.
- 0001628280-24-000693
- Filed
- Jan 5, 2024
- Trade date
- Jan 4-5, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $204.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewis WilliamCIK 0001402051 | Director, Officer (Chair and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | AGrant or awardAcquired | +186,970 | $0.00 | $0 | 186,970 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 6,979 shares sold at prices ranging from $29.24 to $29.26 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.